Targeting the protein kinase C family: are we there yet?

被引：316
作者：
Mackay, Helen J.
Twelves, Christopher J. [1 ]
机构：
[1] Univ Bradford, Inst Canc Therapeut, Bradford BD7 1DP, W Yorkshire, England
[2] Univ Toronto, Princess Margaret Hosp, Dept Haematol & Med Oncol, Toronto, ON, Canada
来源：
NATURE REVIEWS CANCER | 2007年 / 7卷 / 07期
关键词：
BREAST-CANCER CELLS; ANTISENSE OLIGONUCLEOTIDE APRINOCARSEN; SIGNAL-TRANSDUCTION PATHWAYS; GLYCOGEN-SYNTHASE KINASE-3; PHASE-I TRIAL; BETA-II; MULTIDRUG-RESISTANCE; ALPHA EXPRESSION; GROWTH-FACTOR; BRYOSTATIN;
D O I：
10.1038/nrc2168
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Protein kinase C (PKC) comprises a family of serine/ threonine kinases that are involved in the transduction of signals for cell proliferation, differentiation, apoptosis and angiogenesis. Unsurprisingly, disruption of PKC regulation is implicated in tumorigenesis and drug resistance. PKC function is complex in this context owing to the differing roles of individual isozymes within the cell and across tumour types. Therapeutically targeting PKC isozymes is not new; however, with many of the early PKC inhibitor cytotoxic drug combinations being discarded at the phase II level, and recent phase III studies in non-small-cell lung cancer proving negative, what's going wrong?
引用
收藏
页码：554 / 562
页数：9
相关论文
共 132 条
  • [1] What is the right dose? The elusive optimal biologic dose in phase I clinical trials
    Adjei, Alex A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (25) : 4054 - 4055
  • [2] PKC-η mediates glioblastoma cell proliferation through the Akt and mTOR signaling pathways
    Aeder, SE
    Martin, PM
    Soh, JW
    Hussaini, IM
    [J]. ONCOGENE, 2004, 23 (56) : 9062 - 9069
  • [3] AHANG L, 2006, CANCER RES, V66, P4627
  • [4] Protein kinase C alpha expression in normal breast, ductal carcinoma in situ and invasive ductal carcinoma
    Ainsworth, PD
    Winstanley, JHR
    Pearson, JM
    Bishop, HM
    Garrod, DR
    [J]. EUROPEAN JOURNAL OF CANCER, 2004, 40 (15) : 2269 - 2273
  • [5] ANDREJAUSKASBUCHDUNGER E, 1992, CANCER RES, V52, P5353
  • [6] Further evidence that 3-phosphoinositide-dependent protein kinase-1 (PDK1) is required for the stability and phosphorylation of protein kinase C (PKC) isoforms
    Balendran, A
    Hare, GR
    Kieloch, A
    Williams, MR
    Alessi, DR
    [J]. FEBS LETTERS, 2000, 484 (03) : 217 - 223
  • [7] BASU A, 1992, CANCER RES, V52, P3119
  • [8] Anticancer drug-mediated induction of multidrug resistance-associated genes and protein kinase C isozymes in the T-lymphoblastoid cell line CCRF-CEM and in blasts from patients with acute lymphoblastic leukemias
    Beck, JF
    Brügger, D
    Brischwein, K
    Liu, C
    Bader, P
    Niethammer, D
    Gekeler, V
    [J]. JAPANESE JOURNAL OF CANCER RESEARCH, 2001, 92 (08): : 896 - 903
  • [9] Protein kinase C isozymes in colon carcinogenesis: Guilt by omission
    Black, JD
    [J]. GASTROENTEROLOGY, 2001, 120 (07) : 1868 - 1872
  • [10] Blobe GC, 1994, CANCER METAST REV, V13, P724
12345678910